Methods and compositions for treating cancer using peptide nucleic acid-based agents
US-10113169-B2 · Oct 30, 2018 · US
US10160787B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10160787-B2 |
| Application number | US-201815972494-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 7, 2018 |
| Priority date | Apr 8, 2011 |
| Publication date | Dec 25, 2018 |
| Grant date | Dec 25, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described are γ-PNA monomers, methodology for synthesizing them, and methodology for synthesizing PNA oligomers that incorporate them.
Opening claim text (preview).
What is claimed is: 1. A compound according to Formula IIIa wherein, Z is selected from the group consisting of hydroxyl (OH), iodine (I), 4-toluenesulfonate and methanesulfonate; R 5 is selected from the group consisting of hydrogen (H), linear or branched (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 1 -C 8 )hydroxylalkyl, (C 3 -C 8 )aryl, (C 3 -C 8 )cycloalkyl, (C 3 -C 8 )aryl(C 1 -C 6 )alkylene and (C 3 -C 8 )cycloalkyl(C 1 -C 6 )alkylene; P is selected from the group consisting of: 9-fluorenylmethyloxycarbonyl (Fmoc), t-butyloxycarbonyl (Boc), benzyloxycarbonyl (Cbz), benzyl (Bn), tosylate (Tos), allyloxycarbonyl (alloc), benzhydryloxycarbonyl (Bhoc), O-nitroveratryloxycarbonyl (Nvoc), 1-(4,4-dimethyl-2,6-dioxacyclohexylidene)ethyl (Dde), diathiasuccinoyl (Dts), benzothiazole-2-sulfonyl (Bts), trityl (Trt), monomethoxytrityl (MMT) and dimethoxytrityl (DMT); each of R 11 and R 12 is independently selected from the group consisting of hydrogen (H), linear or branched (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 1 -C 8 )hydroxylalkyl, (C 3 -C 8 )aryl, (C 3 -C 8 )cycloalkyl, (C 3 -C 8 )aryl(C 1 -C 6 )alkylene, (C 3 -C 8 )cycloalkyl(C 1 -C 6 )alkylene, provided that at least one of R 11 and R 12 is selected from the group consisting of P 2 is selected from the group consisting of hydrogen (H), linear or branched (C 1 -C 8 )alkyl, 9-fluorenylmethyloxycarbonyl (Fmoc), t-butyloxycarbonyl (Boc), benzyloxycarbonyl (Cbz), benzyl (Bn), tosylate (Tos), allyloxycarbonyl (alloc), trityl (Trt), monomethoxytrityl (MMT) and dimethoxytrityl (DMT); P 3 selected from the group consisting of hydrogen (H), linear or branched (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 3 -C 8 )aryl, (C 3 -C 8 )cycloalkyl, (C 3 -C 8 )aryl(C 1 -C 6 )alkylene and (C 3 -C 8 )cycloalkyl(C 1 -C 6 )alkylene; x is an integer from 1 to 10, inclusive; and y is an integer from 1 to 9, inclusive. 2. The compound of claim 1 , wherein Z is selected from the group consisting of iodine and hydroxyl; R 11 is —CH 2 —[O(CH 2 ) 2 ] x —OR 8 and R 12 is H, wherein x is an integer from 1 to 4 inclusive; R 5 is selected from the group consisting of hydrogen (H) and methyl; and R 8 is selected from the group consisting of hydrogen, methyl, ethyl, and t-butyl. 3. The compound of claim 2 , wherein Z is hydroxyl, R 5 is hydrogen, R 12 is hydrogen and P is 9-fluorenylmethyloxycarbonyl (Fmoc) or t-butyloxycarbonyl (Boc). 4. The compound of claim 3 having the formula IIIa-1: wherein, P 3 is selected from methyl, ethyl and t-butyl. 5. The compound of claim 4 having the formula IIIa-2 or IIIa-3: 6. The compound of claim 5 , having an optical purity of at least 99% enantiomeric excess (ee). 7. The compound of claim 1 , wherein Z is selected from the group consisting of iodine and hydroxyl; R 11 is H and R 12 is —CH 2 —[O(CH 2 ) 2 ] x —OR 8 , wherein x is an integer from 1 to 4 inclusive; R 5 is selected from the group consisting of hydrogen (H) and methyl; and R 8 is selected from the group consisting of hydrogen, methyl, ethyl, and t-butyl. 8. The compound of claim 7 , wherein Z is hydroxyl, R 5 is hydrogen, R 11 is hydrogen and P is 9-fluorenylmethyloxycarbonyl (Fmoc) or t-butyloxycarbonyl (Boc). 9. The compound of claim 8 , having the formula IIIa-4: wherein, P 3 is selected from methyl, ethyl and t-butyl. 10. The compound of claim 9 , having the formula IIIa-5 or IIIa-6: 11. The compound of claim 10 , having an optical purity of at least 99% enantiomeric excess (ee). 12. The compound of claim 1 , wherein Z is hydroxyl (—OH). 13. The compound of claim 1 , wherein Z is iodine (I), 4-toluenesulfonate or methanesulfonate. 14. A method comprising: a) contacting a compound of formula X: wherein, P is selected from the group consisting of: 9-fluorenylmethyloxycarbonyl (Fmoc), t-butyloxycarbonyl (Boc), benzyloxycarbonyl (Cbz), benzyl (Bn), tosylate (Tos), allyloxycarbonyl (alloc), trityl (Trt), monomethoxytrityl (MMT) and dimethoxytrityl (DMT); R 5 is selected from the group consisting of hydrogen (H), linear or branched (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 1 -C 8 )hydroxylalkyl, (C 3 -C 8 )aryl, (C 3 -C 8 )cycloalkyl, (C 3 -C 8 )aryl(C 1 -C 6 )alkylene and (C 3 -C 8 )cycloalkyl(C 1 -C 6 )alkylene; one of R 1 and R 2 is —CH 2 —OH and the other of R 1 and R 2 is H with a compound of formula: P 3 —(O—CH 2 —CH 2 —) x OX, wherein X is CH 3 S(O) 2 —, P 3 is methyl, ethyl, or t-butyl; and x is a number from 1 to 10, inclusive, to thereby obtain a compound of formula XI: wherein one of R 11 and R 12 is —CH 2 —O—(CH 2 —CH 2 —O)x-P 3 and the other of R 11 and R 12 is H; and b) reducing the carboxylic acid of formula XI to an alcohol to thereby produce a compound of formula 15. The method of claim 14 , further comprising: c) contacting said compound of formula with a reagent selected from the group consisting of: methanesulfonyl chloride, 4-toluenesulfonyl chloride and sodium iodide. 16. The method of claim 14 , wherein the compound of formula IIIa-7 has the formula IIIa-1: wherein, P 3 is selected from methyl, ethyl and t-butyl. 17. The method of claim 16 , wherein the compound of formula IIIa-1 has the formula IIIa-2 or IIIa-3: 18. The method of claim 14 , wherein the compound of formula IIIa-7 has the formula IIIa-4: wherein, P 3 is selected from methyl, ethyl and t-butyl. 19. The method of claim 18 , wherein the compound of formula IIIa-4 has the formula IIIa-5 or IIIa-6:
using activating agents {(C07K1/003, C07K1/006 take precedence)} · CPC title
one oxygen and one nitrogen atom, e.g. guanine · CPC title
to carbon atoms of acyclic carbon skeletons · CPC title
as doubly bound oxygen atoms or as unsubstituted hydroxy radicals · CPC title
to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.